Literature DB >> 19536857

Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: a literature review.

G Brandon Gunn1, Karl E Anderson, Abhilasha J Patel, Juan Gallegos, Csilla Kormos Hallberg, Gagan Sood, Sandra S Hatch, Giuseppe Sanguineti.   

Abstract

BACKGROUND: Some porphyrias are associated with cutaneous phototoxicity due to photoactivation of porphyrins, but whether ionizing radiation can have an additive effect is not clear. We report a case of severe radiation therapy-related toxicity in a patient with porphyria cutanea tarda and review the literature.
METHODS: A 50-year-old man with porphyria cutanea was treated for lower lip squamous cell carcinoma with definitive radiation therapy. During radiation therapy, acute toxicity was of an expected onset and severity. Six months after treatment completion, he developed skin hypopigmentation, soft tissue fibrosis, and areas of painful denuded skin and crusting within the previous treatment field.
RESULTS: Reports of 7 patients with porphyria receiving radiation therapy to at least 9 separate sites were reviewed, with only 1 previous report suggestive of increased radiation therapy-related toxicity.
CONCLUSION: Based on this and 1 other report, caution is warranted when considering radiation therapy in patients with active porphyria. 2009 Wiley Periodicals, Inc. Head Neck, 2009.

Entities:  

Mesh:

Year:  2010        PMID: 19536857      PMCID: PMC2891307          DOI: 10.1002/hed.21161

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  20 in total

1.  Vascular changes in erythropoietic protoporphyria: histopathologic and immunohistochemical study.

Authors:  K Timonen; A L Kariniemi; K M Niemi; A M Teppo; R Tenhunen; R Kauppinen
Journal:  J Am Acad Dermatol       Date:  2000-09       Impact factor: 11.527

2.  Porphyrias associated with malignant tumors: results of treatment with ionizing irradiation.

Authors:  M Schaffer; P M Schaffer; M Panzer; R Wilkowski; E Dühmke
Journal:  Onkologie       Date:  2001-04

Review 3.  Modern diagnosis and management of the porphyrias.

Authors:  Shigeru Sassa
Journal:  Br J Haematol       Date:  2006-09-04       Impact factor: 6.998

4.  Cytotoxic chemotherapy and radiotherapy in a patient with breast cancer and variegate porphyria (VP)

Authors:  J D Scarlett; J Corry; P N Jeal
Journal:  Aust N Z J Med       Date:  1995-12

5.  In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.

Authors:  R A Miller; K Woodburn; Q Fan; M F Renschler; J L Sessler; J A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-11-01       Impact factor: 7.038

6.  [Porphyria and radiotherapy: yet a constellation of risk?].

Authors:  Walter Rhomberg; Felix Albert Offner
Journal:  Strahlenther Onkol       Date:  2005-06       Impact factor: 3.621

Review 7.  Making sense of the porphyrias.

Authors:  Robert P E Sarkany
Journal:  Photodermatol Photoimmunol Photomed       Date:  2008-04       Impact factor: 3.135

8.  Mast cells and transforming growth factor-beta expression: a possible relationship in the development of porphyria cutanea tarda skin lesions.

Authors:  Glalcyara Lançoni; Roberto Cuan Ravinal; Roberto Silva Costa; Ana Maria Roselino
Journal:  Int J Dermatol       Date:  2008-06       Impact factor: 2.736

9.  A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.

Authors:  John D Phillips; Hector A Bergonia; Christopher A Reilly; Michael R Franklin; James P Kushner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-09       Impact factor: 11.205

Review 10.  Motexafin gadolinium: a novel radiosensitizer for brain tumors.

Authors:  Afshin Forouzannia; Gregory M Richards; Deepak Khuntia; Minesh P Mehta
Journal:  Expert Rev Anticancer Ther       Date:  2007-06       Impact factor: 4.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.